Name: Glimisave MV 2.2F Tablet SR
Brand: Eris Lifesciences Ltd.
SKU: 1201584
Price: 248.77 INR
Availability: InStock

Question 1

What is Glimisave MV 2.2F Tab SR?

Accepted Answer

Glimisave MV 2.2F Tab SR is a combination of Glimepiride, Metformin, and Voglibose used to treat type 2 diabetes mellitus (DM). It helps improve blood glucose levels when combined with a proper diet and exercise. Glimepiride increases insulin release, Metformin reduces liver glucose production and enhances insulin sensitivity, while Voglibose lowers post-meal glucose levels. It is not for treating Type 1 DM.

Question 2

Can the use of Glimisave MV 2.2F Tab SR cause hypoglycemia?

Accepted Answer

Yes, Glimisave MV 2.2F Tab SR can cause hypoglycemia. Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and anxiety. It is more likely if you miss meals, drink alcohol, over-exercise, or take other antidiabetic medications. Regular blood sugar monitoring is essential, and keep glucose tablets, honey, or fruit juice handy.

Question 3

What are the possible side effects of Glimisave MV 2.2F Tab SR?

Accepted Answer

Common side effects of Glimisave MV 2.2F Tab SR include hypoglycemia, nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection.

Question 4

Is it safe to take alcohol while I am also taking Glimisave MV 2.2F Tab SR?

Accepted Answer

No, consuming alcohol with Glimisave MV 2.2F Tab SR is unsafe as it can lower blood sugar levels and increase the risk of lactic acidosis.

Question 5

What are the instructions for the storage and disposal of Glimisave MV 2.2F Tab SR?

Accepted Answer

Store Glimisave MV 2.2F Tab SR in its original container, tightly closed, and follow the storage instructions on the label. Dispose of unused medicine safely to prevent accidental consumption by pets, children, or others.

Question 6

Are there any specific conditions in which Glimisave MV 2.2F Tab SR should not be taken?

Accepted Answer

Glimisave MV 2.2F Tab SR should be avoided in patients with known allergies to its components, moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, and metabolic acidosis, including diabetic ketoacidosis.

Glimisave MV 2.2F Tablet SR

Eris Lifesciences Ltd.

Eris Lifesciences Ltd.

Leeford Healthcare Ltd.

Customers also bought

Disclaimer

Health Articles

Top Selling Medicines

Top Selling Devices

Health Articles